North America Therapeutic Vaccines Market by Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Therapeutic Vaccines Market by Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 73 | Pages: 140 | December 2016 | Region: North America


The North America Therapeutic Vaccines Market is set to reach $1398.88 Million by 2020 from $365.79 Million in 2015 with a CAGR of 30.77%. Therapeutics vaccines are useful tools that help in treating a disease by strengthening the patient’s immune system.

Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. With USA and Canada averaging around 300 people diagnosed per 100,000 the need for therapeutic vaccines became imminent in the region. The field of cancer immunotherapy received an important boost with the FDA’s approval of the first therapeutic cancer vaccine, which surely results in the positive growth of the market.

The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.

The North America Therapeutic Vaccines Market is segmented by the type of disease into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada. North America accounts for the large portion of revenue in the therapeutic vaccine market. The growth of this market will be boosted owing to the presence of advanced and active R&D establishments in the region.

Some of the key players influencing the North America preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                           

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                      

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 By Disease Type                                       

                                5.1.1 Autoimmune Disease Vaccines                      

                                5.1.2 Cancer Vaccines                    

                                                5.1.2.1 Multikine             

                                                5.1.2.2 PR1 Peptide        

                                                5.1.2.3 TroVax  

                                                5.1.2.4 CYT004-MelQbG10           

                                5.1.3 Neurological Disease Vaccines                        

                                                5.1.3.1 ACC- 001               

                                                5.1.3.2 CAD 106

                                                5.1.3.3 Parkinson's Disease Vaccine        

                                                5.1.3.4 Alzheimer's Disease        

                                5.1.4 Infectious Disease Vaccines                             

                                                5.1.4.1 Hepatitis C           

                                                5.1.4.2 HIV/AIDS              

                                                5.1.4.3 Other Infectious Disease               

  1. Geographical Analysis

                6.1 Introduction                                               

                6.2 United States                                            

                6.3 Canada                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                              

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck and Company                                              

                8.3 Bavarian Nordic                                        

                8.4 CSL Limited                                 

                8.5 Emergent Biosolutions Inc.                                  

                8.6 Novartis AG                                

                8.7 Johnson and Johnson                                            

                8.8 MedImmune LLC                                     

                8.9 Pfizer Inc.                                    

                8.10 Sanofi Pasteur                                        

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  2. North America Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  3. North America Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  4. North America Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  5. North America Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  6. North America Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  7. North America Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  8. North America Multikine Market By Region, From 2015-2020 ( USD Million )
  9. North America PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  10. North America TroVax Market By Region, From 2015-2020 ( USD Million )
  11. North America CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  12. North America Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  13. North America ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  14. North America CAD 106 Market By Region, From 2015-2020 ( USD Million )
  15. North America Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  16. North America Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  17. North America Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  18. North America Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  19. North America HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  20. North America Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  21. United States Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  22. Canada Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  23. United States Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  24. Canada Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  25. United States Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  26. Canada Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  27. United States Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  28. Canada Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
Middle East And Africa Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Applic...
Latin America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Res...
Europe Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research ...
North America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Radioimmunoassay Market By Type (Reagents And Kits Market, Analysers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Cli...
Middle East And Africa Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, G...
Latin America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Asia Pacific Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Ele...
Europe Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrica...
North America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimu...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.